This will eventually roll around the world and many cases will be fought, with taxpayer's on the hook, since Big Pharma shareholders have indemnity, under terms of the agreement our governments rushed to sign. A well executed con-job.
Week 45 Wrap: Combat sports usher in Trump 2.0 – or is it male insecurity?; RBA boring; Propane suggests China alive
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint
